Log in
Enquire now
‌

US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture

Patent 8217149 was granted and assigned to Genentech on July, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
December 8, 2009
0
Date of Patent
July 10, 2012
0
Patent Application Number
12633339
0
Patent Citations Received
‌
US Patent 12129297 Antibodies against TIM3 and uses thereof
0
‌
US Patent 12090142 Combination therapy for the treatment of cancer
0
‌
US Patent 12090147 Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 12103922 Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
0
‌
US Patent 12103954 Heterodimeric Fc cytokines and uses thereof
0
‌
US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
0
‌
US Patent 12110276 Pyrazolo compounds and methods of use thereof
0
‌
US Patent 12110337 Anti-CD27 antibodies and uses thereof
0
‌
US Patent 12115191 Methods of treating age-related and inflammatory diseases
0
‌
US Patent 12121565 Methods of treatment of specific cancers with NLRP3 inhibitors and anti-PD1/PD-L1 antibodies
0
•••
Patent Inventor Names
Bryan Irving
0
Sanjeev Mariathasan
0
Sophie M. Lehar
0
Yan Wu
0
Heather Maecker
0
Henry Chiu
0
Jeanne Cheung
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8217149
0
Patent Primary Examiner
‌
Ilia Ouspenski
0

Find more entities like US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.